A new cohort of iPSC lines available from EBiSC will accelerate research into Huntington’s disease

The European Bank for induced Pluripotent Stem Cells (EBiSC) and CHDI Foundation have collaborated with Censo Biotechnologies to generate a cohort of 45 iPSC lines derived from Huntington’s disease gene-expansion carriers and associated controls. These new lines will be used to further investigate the mechanisms of HD progression and for the development of novel therapeutics. They will be widely available to any interested researcher via the EBiSC catalogue at cells.ebisc.org/.

Source: EBiSC - European Bank for induced pluripotent Stem Cells